Pandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022
JNCI Cancer Spectrum · 07.07.2026 · 10 (4)
DOI: 10.1093/jncics/pkag067 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 22.06.2026. Verfasst von Todd Burus und 1 weiteren Autor:innen. Beteiligte Einrichtung: Markey Cancer Center, University of Kentucky, Lexington, KY, United States. Hauptthemen laut MEDLINE: Neoplasms, COVID-19, Delayed Diagnosis. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
COVID-19 pandemic-related disruptions may have altered pediatric cancer detection in the United States. Using the National Childhood Cancer Registry, we compared observed incidence rates among individuals aged 0-17 years during 2020-2022 with expected rates with 95% credible intervals (CrIs) derived from pre-pandemic trends. Rates were evaluated overall and by race/ethnicity, cancer site, and stage-at-diagnosis. Among 27 996 cancers diagnosed in 2020-2022, total incidence was 17.44 per 100 000, similar to the expected rate of 17.39 (95% CrI = 16.80-17.98). Annual patterns showed an incidence reduction in 2020, followed by modestly higher-than-expected rates in 2021-2022. Pandemic-era late-stage incidence was significantly higher than expected, however (10.58 vs 10.19 per 100 000). Overall, pediatric cancer incidence during the COVID-19 pandemic matched expectations, but late-stage diagnoses increased, underscoring the need to restore timely evaluation and maintain diagnostic access during health-system disruptions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Markey Cancer Center, University of Kentucky, Lexington, KY, United States.
- Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, KY, United States.
- Department of Public Health, Des Moines University College of Health Sciences, West Des Moines, IA, United States.
ORCID-Profile: Todd Burus, Jason Semprini
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Burus, T., & Semprini, J. (2026). Pandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022. JNCI Cancer Spectrum, 10(4). https://doi.org/10.1093/jncics/pkag067
Vancouver
Burus T, Semprini J. Pandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022. JNCI Cancer Spectrum. 2026;10(4). doi:10.1093/jncics/pkag067
BibTeX
@article{Burus2026,
author = {Burus, Todd and Semprini, Jason},
title = {Pandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022},
journal = {JNCI Cancer Spectrum},
year = {2026},
volume = {10},
number = {4},
doi = {10.1093/jncics/pkag067}
}
EUVIMED